Switch theme
Sign up to access all valuation multiples
Oxiquim SA focuses on the marketing of chemical products and the provision of services related to the chemical sector. It is engaged in the production, transformation, sale, export, and distribution of all types of chemical, petrochemical, pharmaceutical, cosmetic, and general chemical products. The company's other business activities include the provision of engineering and maintenance services, the operation and exploitation of maritime terminals, and the production and sale of resins and adhesive mixtures. The company's operating segments are; Commercial which derives maximum revenue, and Services.
1980
428
Last FY Revenue $243M
Last FY EBITDA $40.9M
$341M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Oxiquim achieved revenue of $243M and an EBITDA of $40.9M.
Oxiquim expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Oxiquim valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $243M | XXX | XXX | XXX |
| Gross Profit | XXX | $88.1M | XXX | XXX | XXX |
| Gross Margin | XXX | 36% | XXX | XXX | XXX |
| EBITDA | XXX | $40.9M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 17% | XXX | XXX | XXX |
| EBIT | XXX | $35.4M | XXX | XXX | XXX |
| EBIT Margin | XXX | 15% | XXX | XXX | XXX |
| Net Profit | XXX | $27.2M | XXX | XXX | XXX |
| Net Margin | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | $50.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Oxiquim's stock price is CLP 11500 (or $12).
Oxiquim has current market cap of CLP 286B (or $296M), and EV of CLP 330B (or $341M).
See Oxiquim trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $341M | $296M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Oxiquim has market cap of $296M and EV of $341M.
Oxiquim's trades at 1.4x EV/Revenue multiple, and 8.3x EV/EBITDA.
Equity research analysts estimate Oxiquim's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Oxiquim's P/E ratio is not available.
See valuation multiples for Oxiquim and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $296M | XXX | $296M | XXX | XXX | XXX |
| EV (current) | $341M | XXX | $341M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 8.3x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 9.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 10.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 17.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOxiquim's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.1M for the same period.
Oxiquim's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Oxiquim's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Oxiquim and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 22% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Oxiquim acquired XXX companies to date.
Last acquisition by Oxiquim was XXXXXXXX, XXXXX XXXXX XXXXXX . Oxiquim acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Oxiquim founded? | Oxiquim was founded in 1980. |
| Where is Oxiquim headquartered? | Oxiquim is headquartered in Chile. |
| How many employees does Oxiquim have? | As of today, Oxiquim has 428 employees. |
| Is Oxiquim publicy listed? | Yes, Oxiquim is a public company listed on SGO. |
| What is the stock symbol of Oxiquim? | Oxiquim trades under OXIQUIM ticker. |
| When did Oxiquim go public? | Oxiquim went public in 2015. |
| Who are competitors of Oxiquim? | Similar companies to Oxiquim include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of Oxiquim? | Oxiquim's current market cap is $296M |
| Is Oxiquim profitable? | Yes, Oxiquim is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
